Disruption of CD40/CD40L interaction influences the course of Cryptococcus neoformans infection. (Q47253136)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14734188%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

title

Disruption of CD40/CD40L interaction influences the course of Cryptococcus neoformans infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14734188%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

main subject

Cryptococcus neoformans

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14734188%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Donatella Pietrella

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14734188%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Stefano Perito

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14734188%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Paolo Mosci

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14734188%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

5

Francesco Bistoni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14734188%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

author name string

Patrizia Lupo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14734188%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14734188%20AND%20SRC:MED&resulttype=core&format=json

FEMS Immunology and Medical Microbiology

17 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14734188%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14734188%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14734188%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

page(s)

63-70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14734188%20AND%20SRC:MED&resulttype=core&format=json

Prospects for CD40-directed experimental therapy of human cancer

17 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900297-9

7 January 2021

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900297-9

7 January 2021

Apoptosis induced by Pseudomonas aeruginosa in antigen presenting cells is diminished by genetic modification with CD40 ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900297-9

7 January 2021

Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900297-9

7 January 2021

CD40/CD40 ligand interactions in the host defense against disseminated Candida albicans infection: the role of macrophage-derived nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900297-9

7 January 2021

Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900297-9

7 January 2021

CD40 ligand is required for protective cell-mediated immunity to Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900297-9

7 January 2021

Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900297-9

7 January 2021

The development of a Th1-type response and resistance to Leishmania major infection in the absence of CD40-CD40L costimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900297-9

7 January 2021

CD40 ligand (CD154) does not contribute to lymphocyte-mediated inhibition of virulent Mycobacterium tuberculosis within human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900297-9

7 January 2021

CD40 ligand is not essential for induction of type 1 cytokine responses or protective immunity after primary or secondary infection with histoplasma capsulatum

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900297-9

7 January 2021

Persistence of initial infection in recurrent Cryptococcus neoformans meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900297-9

7 January 2021

T lymphocyte and monocyte interaction by CD40/CD40 ligand facilitates a lymphoproliferative response and killing of Cryptococcus neoformans in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900297-9

7 January 2021

Encapsulation of Cryptococcus neoformans regulates fungicidal activity and the antigen presentation process in human alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900297-9

7 January 2021

Cytokines and T cells in host defense

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900297-9

7 January 2021

IFN-alpha and IL-12 induce IL-18 receptor gene expression in human NK and T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900297-9

7 January 2021

The role of B7 co-stimulation in activation and differentiation of CD4+ and CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900297-9

7 January 2021

CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900297-9

7 January 2021

CTLA-4 and T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900297-9

7 January 2021

10.1016/S0928-8244(03)00297-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14734188%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

1 reference